ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.33 per share which beat the analyst consensus estimate of $2.00 by 16.79 percent. This is a 42.94 percent increase over earnings of $1.63 per share from the same period last year. The company reported quarterly sales of $247.060 million which beat the analyst consensus estimate of $231.534 million by 6.71 percent. This is a 29.64 percent increase over sales of $190.574 million the same period last year.